Missing/wrong data?
Log in to edit
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.
scientific article
Author/s
author: Jourik A. Gietema, Elisabeth de Vries, Stefan Sleijfer, Jaap Verweij, Ferry Eskens
Work details
Publication date
August 18, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.